                         SEQUENCE LISTING

<110>  ULTRAHUMAN SIX LIMITED
 
<120>  C-MET BINDING AGENTS

<130>  ULSL-001/03WO 332949-2004

<150>  GB 1816841.9
<151>  2018-10-16

<150>  GB 1812487.5
<151>  2018-07-21

<150>  GB 1803892.7
<151>  2018-03-12

<160>  255   

<170>  PatentIn version 3.5

<210>  1
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody MH7-3 heavy chain variable (VH) region

<400>  1

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gln Glu Ile Thr Thr Glu Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody MH7-3 light chain variable (VL) region

<400>  2

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Ala Gln Ser Tyr Leu His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro 
        35                  40                  45              


Arg Leu Leu Ile Tyr Arg Gly Ser Thr Arg Glu Thr Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Ser Lys 
                85                  90                  95      


Glu Ser Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  3
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody MH7-2 heavy chain variable (VH) region

<400>  3

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gln Glu Ile Thr Thr Glu Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  4
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody MH7-2 light chain variable (VL) region

<400>  4

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Ala Asn Ser Tyr Leu His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro 
        35                  40                  45              


Arg Leu Leu Ile Tyr Arg Gly Ser Thr Arg Glu Thr Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Ser Lys 
                85                  90                  95      


Glu Ser Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  5
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody MH7-1 heavy chain variable (VH) region

<400>  5

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gln Glu Ile Thr Thr Glu Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  6
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody MH7-1 light chain variable (VL) region

<400>  6

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Ala Asn Ser Tyr Leu His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro 
        35                  40                  45              


Arg Leu Leu Ile Tyr Arg Gly Ser Thr Arg Glu Thr Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Ser Lys 
                85                  90                  95      


Ser Glu Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  7
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody MH7 heavy chain variable (VH) region

<400>  7

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gln Glu Ile Thr Thr Glu Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  8
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody MH7 light chain variable (VL) region

<400>  8

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Ala Asn Ser Tyr Leu His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro 
        35                  40                  45              


Arg Leu Leu Ile Tyr Arg Gly Ser Thr Arg Glu Ser Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Ser Lys 
                85                  90                  95      


Ser Glu Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  9
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody 08G07 heavy chain variable (VH) region

<400>  9

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Pro Ser Gly Gly Leu Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Glu Ile Thr Thr Asp Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  10
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  Antibody 08G07 light chain variable (VL) region

<400>  10

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asp Ser Tyr 
            20                  25                  30          


Ala Asn Ser Tyr Leu His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro 
        35                  40                  45              


Arg Leu Leu Ile Tyr Arg Gly Ser Thr Arg Glu Ser Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Ser Lys 
                85                  90                  95      


Ser Glu Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  11
<211>  327
<212>  PRT
<213>  Homo sapiens

<400>  11

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg 
1               5                   10                  15      


Ser Thr Ser Glu Ser Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr 
65                  70                  75                  80  


Tyr Thr Cys Asn Val Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Arg Val Glu Ser Lys Tyr Gly Pro Pro Cys Pro Ser Cys Pro Ala Pro 
            100                 105                 110         


Glu Phe Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys 
        115                 120                 125             


Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val 
    130                 135                 140                 


Asp Val Ser Gln Glu Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp 
145                 150                 155                 160 


Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe 
                165                 170                 175     


Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp 
            180                 185                 190         


Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu 
        195                 200                 205             


Pro Ser Ser Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg 
    210                 215                 220                 


Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys 
225                 230                 235                 240 


Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp 
                245                 250                 255     


Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys 
            260                 265                 270         


Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser 
        275                 280                 285             


Arg Leu Thr Val Asp Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser 
    290                 295                 300                 


Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser 
305                 310                 315                 320 


Leu Ser Leu Ser Leu Gly Lys 
                325         


<210>  12
<211>  327
<212>  PRT
<213>  Homo sapiens

<400>  12

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg 
1               5                   10                  15      


Ser Thr Ser Glu Ser Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr 
65                  70                  75                  80  


Tyr Thr Cys Asn Val Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Arg Val Glu Ser Lys Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro 
            100                 105                 110         


Glu Phe Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys 
        115                 120                 125             


Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val 
    130                 135                 140                 


Asp Val Ser Gln Glu Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp 
145                 150                 155                 160 


Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe 
                165                 170                 175     


Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp 
            180                 185                 190         


Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu 
        195                 200                 205             


Pro Ser Ser Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg 
    210                 215                 220                 


Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys 
225                 230                 235                 240 


Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp 
                245                 250                 255     


Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys 
            260                 265                 270         


Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser 
        275                 280                 285             


Arg Leu Thr Val Asp Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser 
    290                 295                 300                 


Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser 
305                 310                 315                 320 


Leu Ser Leu Ser Leu Gly Lys 
                325         


<210>  13
<211>  330
<212>  PRT
<213>  Homo sapiens

<400>  13

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys 
1               5                   10                  15      


Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr 
65                  70                  75                  80  


Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys 
            100                 105                 110         


Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro 
        115                 120                 125             


Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys 
    130                 135                 140                 


Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp 
145                 150                 155                 160 


Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu 
                165                 170                 175     


Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu 
            180                 185                 190         


His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn 
        195                 200                 205             


Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly 
    210                 215                 220                 


Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu 
225                 230                 235                 240 


Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr 
                245                 250                 255     


Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn 
            260                 265                 270         


Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe 
        275                 280                 285             


Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn 
    290                 295                 300                 


Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr 
305                 310                 315                 320 


Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
                325                 330 


<210>  14
<211>  330
<212>  PRT
<213>  Homo sapiens

<400>  14

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys 
1               5                   10                  15      


Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr 
65                  70                  75                  80  


Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys 
            100                 105                 110         


Pro Ala Pro Glu Ala Ala Gly Ala Pro Ser Val Phe Leu Phe Pro Pro 
        115                 120                 125             


Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys 
    130                 135                 140                 


Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp 
145                 150                 155                 160 


Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu 
                165                 170                 175     


Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu 
            180                 185                 190         


His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn 
        195                 200                 205             


Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly 
    210                 215                 220                 


Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu 
225                 230                 235                 240 


Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr 
                245                 250                 255     


Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn 
            260                 265                 270         


Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe 
        275                 280                 285             


Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn 
    290                 295                 300                 


Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr 
305                 310                 315                 320 


Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
                325                 330 


<210>  15
<211>  326
<212>  PRT
<213>  Homo sapiens

<400>  15

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg 
1               5                   10                  15      


Ser Thr Ser Glu Ser Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Asn Phe Gly Thr Gln Thr 
65                  70                  75                  80  


Tyr Thr Cys Asn Val Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Thr Val Glu Arg Lys Cys Cys Val Glu Cys Pro Pro Cys Pro Ala Pro 
            100                 105                 110         


Pro Val Ala Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp 
        115                 120                 125             


Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp 
    130                 135                 140                 


Val Ser His Glu Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly 
145                 150                 155                 160 


Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn 
                165                 170                 175     


Ser Thr Phe Arg Val Val Ser Val Leu Thr Val Val His Gln Asp Trp 
            180                 185                 190         


Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro 
        195                 200                 205             


Ala Pro Ile Glu Lys Thr Ile Ser Lys Thr Lys Gly Gln Pro Arg Glu 
    210                 215                 220                 


Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn 
225                 230                 235                 240 


Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile 
                245                 250                 255     


Ser Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr 
            260                 265                 270         


Thr Pro Pro Met Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys 
        275                 280                 285             


Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys 
    290                 295                 300                 


Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu 
305                 310                 315                 320 


Ser Leu Ser Pro Gly Lys 
                325     


<210>  16
<211>  330
<212>  PRT
<213>  Homo sapiens

<400>  16

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys 
1               5                   10                  15      


Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr 
65                  70                  75                  80  


Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys 
            100                 105                 110         


Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro 
        115                 120                 125             


Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys 
    130                 135                 140                 


Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp 
145                 150                 155                 160 


Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu 
                165                 170                 175     


Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu 
            180                 185                 190         


His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn 
        195                 200                 205             


Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly 
    210                 215                 220                 


Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu 
225                 230                 235                 240 


Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr 
                245                 250                 255     


Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn 
            260                 265                 270         


Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe 
        275                 280                 285             


Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn 
    290                 295                 300                 


Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr 
305                 310                 315                 320 


Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
                325                 330 


<210>  17
<211>  329
<212>  PRT
<213>  Homo sapiens

<400>  17

Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys 
1               5                   10                  15      


Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr 
65                  70                  75                  80  


Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys 
            100                 105                 110         


Pro Ala Pro Glu Ala Ala Gly Ala Pro Ser Val Phe Leu Phe Pro Pro 
        115                 120                 125             


Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys 
    130                 135                 140                 


Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp 
145                 150                 155                 160 


Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu 
                165                 170                 175     


Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu 
            180                 185                 190         


His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn 
        195                 200                 205             


Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly 
    210                 215                 220                 


Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu 
225                 230                 235                 240 


Met Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro 
                245                 250                 255     


Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn 
            260                 265                 270         


Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu 
        275                 280                 285             


Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val 
    290                 295                 300                 


Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln 
305                 310                 315                 320 


Lys Ser Leu Ser Leu Ser Pro Gly Lys 
                325                 


<210>  18
<211>  1390
<212>  PRT
<213>  Homo sapiens

<400>  18

Met Lys Ala Pro Ala Val Leu Ala Pro Gly Ile Leu Val Leu Leu Phe 
1               5                   10                  15      


Thr Leu Val Gln Arg Ser Asn Gly Glu Cys Lys Glu Ala Leu Ala Lys 
            20                  25                  30          


Ser Glu Met Asn Val Asn Met Lys Tyr Gln Leu Pro Asn Phe Thr Ala 
        35                  40                  45              


Glu Thr Pro Ile Gln Asn Val Ile Leu His Glu His His Ile Phe Leu 
    50                  55                  60                  


Gly Ala Thr Asn Tyr Ile Tyr Val Leu Asn Glu Glu Asp Leu Gln Lys 
65                  70                  75                  80  


Val Ala Glu Tyr Lys Thr Gly Pro Val Leu Glu His Pro Asp Cys Phe 
                85                  90                  95      


Pro Cys Gln Asp Cys Ser Ser Lys Ala Asn Leu Ser Gly Gly Val Trp 
            100                 105                 110         


Lys Asp Asn Ile Asn Met Ala Leu Val Val Asp Thr Tyr Tyr Asp Asp 
        115                 120                 125             


Gln Leu Ile Ser Cys Gly Ser Val Asn Arg Gly Thr Cys Gln Arg His 
    130                 135                 140                 


Val Phe Pro His Asn His Thr Ala Asp Ile Gln Ser Glu Val His Cys 
145                 150                 155                 160 


Ile Phe Ser Pro Gln Ile Glu Glu Pro Ser Gln Cys Pro Asp Cys Val 
                165                 170                 175     


Val Ser Ala Leu Gly Ala Lys Val Leu Ser Ser Val Lys Asp Arg Phe 
            180                 185                 190         


Ile Asn Phe Phe Val Gly Asn Thr Ile Asn Ser Ser Tyr Phe Pro Asp 
        195                 200                 205             


His Pro Leu His Ser Ile Ser Val Arg Arg Leu Lys Glu Thr Lys Asp 
    210                 215                 220                 


Gly Phe Met Phe Leu Thr Asp Gln Ser Tyr Ile Asp Val Leu Pro Glu 
225                 230                 235                 240 


Phe Arg Asp Ser Tyr Pro Ile Lys Tyr Val His Ala Phe Glu Ser Asn 
                245                 250                 255     


Asn Phe Ile Tyr Phe Leu Thr Val Gln Arg Glu Thr Leu Asp Ala Gln 
            260                 265                 270         


Thr Phe His Thr Arg Ile Ile Arg Phe Cys Ser Ile Asn Ser Gly Leu 
        275                 280                 285             


His Ser Tyr Met Glu Met Pro Leu Glu Cys Ile Leu Thr Glu Lys Arg 
    290                 295                 300                 


Lys Lys Arg Ser Thr Lys Lys Glu Val Phe Asn Ile Leu Gln Ala Ala 
305                 310                 315                 320 


Tyr Val Ser Lys Pro Gly Ala Gln Leu Ala Arg Gln Ile Gly Ala Ser 
                325                 330                 335     


Leu Asn Asp Asp Ile Leu Phe Gly Val Phe Ala Gln Ser Lys Pro Asp 
            340                 345                 350         


Ser Ala Glu Pro Met Asp Arg Ser Ala Met Cys Ala Phe Pro Ile Lys 
        355                 360                 365             


Tyr Val Asn Asp Phe Phe Asn Lys Ile Val Asn Lys Asn Asn Val Arg 
    370                 375                 380                 


Cys Leu Gln His Phe Tyr Gly Pro Asn His Glu His Cys Phe Asn Arg 
385                 390                 395                 400 


Thr Leu Leu Arg Asn Ser Ser Gly Cys Glu Ala Arg Arg Asp Glu Tyr 
                405                 410                 415     


Arg Thr Glu Phe Thr Thr Ala Leu Gln Arg Val Asp Leu Phe Met Gly 
            420                 425                 430         


Gln Phe Ser Glu Val Leu Leu Thr Ser Ile Ser Thr Phe Ile Lys Gly 
        435                 440                 445             


Asp Leu Thr Ile Ala Asn Leu Gly Thr Ser Glu Gly Arg Phe Met Gln 
    450                 455                 460                 


Val Val Val Ser Arg Ser Gly Pro Ser Thr Pro His Val Asn Phe Leu 
465                 470                 475                 480 


Leu Asp Ser His Pro Val Ser Pro Glu Val Ile Val Glu His Thr Leu 
                485                 490                 495     


Asn Gln Asn Gly Tyr Thr Leu Val Ile Thr Gly Lys Lys Ile Thr Lys 
            500                 505                 510         


Ile Pro Leu Asn Gly Leu Gly Cys Arg His Phe Gln Ser Cys Ser Gln 
        515                 520                 525             


Cys Leu Ser Ala Pro Pro Phe Val Gln Cys Gly Trp Cys His Asp Lys 
    530                 535                 540                 


Cys Val Arg Ser Glu Glu Cys Leu Ser Gly Thr Trp Thr Gln Gln Ile 
545                 550                 555                 560 


Cys Leu Pro Ala Ile Tyr Lys Val Phe Pro Asn Ser Ala Pro Leu Glu 
                565                 570                 575     


Gly Gly Thr Arg Leu Thr Ile Cys Gly Trp Asp Phe Gly Phe Arg Arg 
            580                 585                 590         


Asn Asn Lys Phe Asp Leu Lys Lys Thr Arg Val Leu Leu Gly Asn Glu 
        595                 600                 605             


Ser Cys Thr Leu Thr Leu Ser Glu Ser Thr Met Asn Thr Leu Lys Cys 
    610                 615                 620                 


Thr Val Gly Pro Ala Met Asn Lys His Phe Asn Met Ser Ile Ile Ile 
625                 630                 635                 640 


Ser Asn Gly His Gly Thr Thr Gln Tyr Ser Thr Phe Ser Tyr Val Asp 
                645                 650                 655     


Pro Val Ile Thr Ser Ile Ser Pro Lys Tyr Gly Pro Met Ala Gly Gly 
            660                 665                 670         


Thr Leu Leu Thr Leu Thr Gly Asn Tyr Leu Asn Ser Gly Asn Ser Arg 
        675                 680                 685             


His Ile Ser Ile Gly Gly Lys Thr Cys Thr Leu Lys Ser Val Ser Asn 
    690                 695                 700                 


Ser Ile Leu Glu Cys Tyr Thr Pro Ala Gln Thr Ile Ser Thr Glu Phe 
705                 710                 715                 720 


Ala Val Lys Leu Lys Ile Asp Leu Ala Asn Arg Glu Thr Ser Ile Phe 
                725                 730                 735     


Ser Tyr Arg Glu Asp Pro Ile Val Tyr Glu Ile His Pro Thr Lys Ser 
            740                 745                 750         


Phe Ile Ser Gly Gly Ser Thr Ile Thr Gly Val Gly Lys Asn Leu Asn 
        755                 760                 765             


Ser Val Ser Val Pro Arg Met Val Ile Asn Val His Glu Ala Gly Arg 
    770                 775                 780                 


Asn Phe Thr Val Ala Cys Gln His Arg Ser Asn Ser Glu Ile Ile Cys 
785                 790                 795                 800 


Cys Thr Thr Pro Ser Leu Gln Gln Leu Asn Leu Gln Leu Pro Leu Lys 
                805                 810                 815     


Thr Lys Ala Phe Phe Met Leu Asp Gly Ile Leu Ser Lys Tyr Phe Asp 
            820                 825                 830         


Leu Ile Tyr Val His Asn Pro Val Phe Lys Pro Phe Glu Lys Pro Val 
        835                 840                 845             


Met Ile Ser Met Gly Asn Glu Asn Val Leu Glu Ile Lys Gly Asn Asp 
    850                 855                 860                 


Ile Asp Pro Glu Ala Val Lys Gly Glu Val Leu Lys Val Gly Asn Lys 
865                 870                 875                 880 


Ser Cys Glu Asn Ile His Leu His Ser Glu Ala Val Leu Cys Thr Val 
                885                 890                 895     


Pro Asn Asp Leu Leu Lys Leu Asn Ser Glu Leu Asn Ile Glu Trp Lys 
            900                 905                 910         


Gln Ala Ile Ser Ser Thr Val Leu Gly Lys Val Ile Val Gln Pro Asp 
        915                 920                 925             


Gln Asn Phe Thr Gly Leu Ile Ala Gly Val Val Ser Ile Ser Thr Ala 
    930                 935                 940                 


Leu Leu Leu Leu Leu Gly Phe Phe Leu Trp Leu Lys Lys Arg Lys Gln 
945                 950                 955                 960 


Ile Lys Asp Leu Gly Ser Glu Leu Val Arg Tyr Asp Ala Arg Val His 
                965                 970                 975     


Thr Pro His Leu Asp Arg Leu Val Ser Ala Arg Ser Val Ser Pro Thr 
            980                 985                 990         


Thr Glu Met Val Ser Asn Glu Ser  Val Asp Tyr Arg Ala  Thr Phe Pro 
        995                 1000                 1005             


Glu Asp  Gln Phe Pro Asn Ser  Ser Gln Asn Gly Ser  Cys Arg Gln 
    1010                 1015                 1020             


Val Gln  Tyr Pro Leu Thr Asp  Met Ser Pro Ile Leu  Thr Ser Gly 
    1025                 1030                 1035             


Asp Ser  Asp Ile Ser Ser Pro  Leu Leu Gln Asn Thr  Val His Ile 
    1040                 1045                 1050             


Asp Leu  Ser Ala Leu Asn Pro  Glu Leu Val Gln Ala  Val Gln His 
    1055                 1060                 1065             


Val Val  Ile Gly Pro Ser Ser  Leu Ile Val His Phe  Asn Glu Val 
    1070                 1075                 1080             


Ile Gly  Arg Gly His Phe Gly  Cys Val Tyr His Gly  Thr Leu Leu 
    1085                 1090                 1095             


Asp Asn  Asp Gly Lys Lys Ile  His Cys Ala Val Lys  Ser Leu Asn 
    1100                 1105                 1110             


Arg Ile  Thr Asp Ile Gly Glu  Val Ser Gln Phe Leu  Thr Glu Gly 
    1115                 1120                 1125             


Ile Ile  Met Lys Asp Phe Ser  His Pro Asn Val Leu  Ser Leu Leu 
    1130                 1135                 1140             


Gly Ile  Cys Leu Arg Ser Glu  Gly Ser Pro Leu Val  Val Leu Pro 
    1145                 1150                 1155             


Tyr Met  Lys His Gly Asp Leu  Arg Asn Phe Ile Arg  Asn Glu Thr 
    1160                 1165                 1170             


His Asn  Pro Thr Val Lys Asp  Leu Ile Gly Phe Gly  Leu Gln Val 
    1175                 1180                 1185             


Ala Lys  Gly Met Lys Tyr Leu  Ala Ser Lys Lys Phe  Val His Arg 
    1190                 1195                 1200             


Asp Leu  Ala Ala Arg Asn Cys  Met Leu Asp Glu Lys  Phe Thr Val 
    1205                 1210                 1215             


Lys Val  Ala Asp Phe Gly Leu  Ala Arg Asp Met Tyr  Asp Lys Glu 
    1220                 1225                 1230             


Tyr Tyr  Ser Val His Asn Lys  Thr Gly Ala Lys Leu  Pro Val Lys 
    1235                 1240                 1245             


Trp Met  Ala Leu Glu Ser Leu  Gln Thr Gln Lys Phe  Thr Thr Lys 
    1250                 1255                 1260             


Ser Asp  Val Trp Ser Phe Gly  Val Leu Leu Trp Glu  Leu Met Thr 
    1265                 1270                 1275             


Arg Gly  Ala Pro Pro Tyr Pro  Asp Val Asn Thr Phe  Asp Ile Thr 
    1280                 1285                 1290             


Val Tyr  Leu Leu Gln Gly Arg  Arg Leu Leu Gln Pro  Glu Tyr Cys 
    1295                 1300                 1305             


Pro Asp  Pro Leu Tyr Glu Val  Met Leu Lys Cys Trp  His Pro Lys 
    1310                 1315                 1320             


Ala Glu  Met Arg Pro Ser Phe  Ser Glu Leu Val Ser  Arg Ile Ser 
    1325                 1330                 1335             


Ala Ile  Phe Ser Thr Phe Ile  Gly Glu His Tyr Val  His Val Asn 
    1340                 1345                 1350             


Ala Thr  Tyr Val Asn Val Lys  Cys Val Ala Pro Tyr  Pro Ser Leu 
    1355                 1360                 1365             


Leu Ser  Ser Glu Asp Asn Ala  Asp Asp Glu Val Asp  Thr Arg Pro 
    1370                 1375                 1380             


Ala Ser  Phe Trp Glu Thr Ser  
    1385                 1390 


<210>  19
<211>  1381
<212>  PRT
<213>  Macaca fascicularis

<400>  19

Met Lys Ala Pro Ala Val Leu Val Pro Gly Ile Leu Val Leu Leu Phe 
1               5                   10                  15      


Thr Leu Val Gln Arg Ser Asn Gly Glu Cys Lys Glu Ala Leu Ala Lys 
            20                  25                  30          


Ser Glu Met Asn Val Asn Met Lys Tyr Gln Leu Pro Asn Phe Thr Ala 
        35                  40                  45              


Glu Thr Ala Ile Gln Asn Val Ile Leu His Glu His His Ile Phe Leu 
    50                  55                  60                  


Gly Ala Thr Asn Tyr Ile Tyr Val Leu Asn Glu Glu Asp Leu Gln Lys 
65                  70                  75                  80  


Val Ala Glu Tyr Lys Thr Gly Pro Val Leu Glu His Pro Asp Cys Phe 
                85                  90                  95      


Pro Cys Gln Asp Cys Ser Ser Lys Ala Asn Leu Ser Gly Gly Val Trp 
            100                 105                 110         


Lys Asp Asn Ile Asn Met Ala Leu Val Val Asp Thr Tyr Tyr Asp Asp 
        115                 120                 125             


Gln Leu Ile Ser Cys Gly Ser Val Asn Arg Gly Thr Cys Gln Arg His 
    130                 135                 140                 


Val Phe Pro His Asn His Thr Ala Asp Ile Gln Ser Glu Val His Cys 
145                 150                 155                 160 


Ile Phe Ser Pro Gln Ile Glu Glu Pro Asn Gln Cys Pro Asp Cys Val 
                165                 170                 175     


Val Ser Ala Leu Gly Ala Lys Val Leu Ser Ser Val Lys Asp Arg Phe 
            180                 185                 190         


Ile Asn Phe Phe Val Gly Asn Thr Ile Asn Ser Ser Tyr Phe Pro His 
        195                 200                 205             


His Pro Leu His Ser Ile Ser Val Arg Arg Leu Lys Glu Thr Lys Asp 
    210                 215                 220                 


Gly Phe Met Phe Leu Thr Asp Gln Ser Tyr Ile Asp Val Leu Pro Glu 
225                 230                 235                 240 


Phe Arg Asp Ser Tyr Pro Ile Lys Tyr Ile His Ala Phe Glu Ser Asn 
                245                 250                 255     


Asn Phe Ile Tyr Phe Leu Thr Val Gln Arg Glu Thr Leu Asn Ala Gln 
            260                 265                 270         


Thr Phe His Thr Arg Ile Ile Arg Phe Cys Ser Leu Asn Ser Gly Leu 
        275                 280                 285             


His Ser Tyr Met Glu Met Pro Leu Glu Cys Ile Leu Thr Glu Lys Arg 
    290                 295                 300                 


Lys Lys Arg Ser Thr Lys Lys Glu Val Phe Asn Ile Leu Gln Ala Ala 
305                 310                 315                 320 


Tyr Val Ser Lys Pro Gly Ala Gln Leu Ala Arg Gln Ile Gly Ala Ser 
                325                 330                 335     


Leu Asn Asp Asp Ile Leu Phe Gly Val Phe Ala Gln Ser Lys Pro Asp 
            340                 345                 350         


Ser Ala Glu Pro Met Asp Arg Ser Ala Met Cys Ala Phe Pro Ile Lys 
        355                 360                 365             


Tyr Val Asn Asp Phe Phe Asn Lys Ile Val Asn Lys Asn Asn Val Arg 
    370                 375                 380                 


Cys Leu Gln His Phe Tyr Gly Pro Asn His Glu His Cys Phe Asn Arg 
385                 390                 395                 400 


Thr Leu Leu Arg Asn Ser Ser Gly Cys Glu Ala Arg Arg Asp Glu Tyr 
                405                 410                 415     


Arg Ala Glu Phe Thr Thr Ala Leu Gln Arg Val Asp Leu Phe Met Gly 
            420                 425                 430         


Gln Phe Ser Glu Val Leu Leu Thr Ser Ile Ser Thr Phe Val Lys Gly 
        435                 440                 445             


Asp Leu Thr Ile Ala Asn Leu Gly Thr Ser Glu Gly Arg Phe Met Gln 
    450                 455                 460                 


Val Val Val Ser Arg Ser Gly Pro Ser Thr Pro His Val Asn Phe Leu 
465                 470                 475                 480 


Leu Asp Ser His Pro Val Ser Pro Glu Val Ile Val Glu His Pro Leu 
                485                 490                 495     


Asn Gln Asn Gly Tyr Thr Leu Val Val Thr Gly Lys Lys Ile Thr Lys 
            500                 505                 510         


Ile Pro Leu Asn Gly Leu Gly Cys Arg His Phe Gln Ser Cys Ser Gln 
        515                 520                 525             


Cys Leu Ser Ala Pro Pro Phe Val Gln Cys Gly Trp Cys His Asp Lys 
    530                 535                 540                 


Cys Val Arg Ser Glu Glu Cys Pro Ser Gly Thr Trp Thr Gln Gln Ile 
545                 550                 555                 560 


Cys Leu Pro Ala Ile Tyr Lys Val Phe Pro Thr Ser Ala Pro Leu Glu 
                565                 570                 575     


Gly Gly Thr Arg Leu Thr Ile Cys Gly Trp Asp Phe Gly Phe Arg Arg 
            580                 585                 590         


Asn Asn Lys Phe Asp Leu Lys Lys Thr Arg Val Leu Leu Gly Asn Glu 
        595                 600                 605             


Ser Cys Thr Leu Thr Leu Ser Glu Ser Thr Met Asn Thr Leu Lys Cys 
    610                 615                 620                 


Thr Val Gly Pro Ala Met Asn Lys His Phe Asn Met Ser Ile Ile Ile 
625                 630                 635                 640 


Ser Asn Gly His Gly Thr Thr Gln Tyr Ser Thr Phe Ser Tyr Val Asp 
                645                 650                 655     


Pro Ile Ile Thr Ser Ile Ser Pro Lys Tyr Gly Pro Met Ala Gly Gly 
            660                 665                 670         


Thr Leu Leu Thr Leu Thr Gly Asn Tyr Leu Asn Ser Gly Asn Ser Arg 
        675                 680                 685             


His Ile Ser Ile Gly Gly Lys Thr Cys Thr Leu Lys Ser Val Ser Asn 
    690                 695                 700                 


Ser Ile Leu Glu Cys Tyr Thr Pro Ala Gln Thr Ile Ser Thr Glu Phe 
705                 710                 715                 720 


Ala Val Lys Leu Lys Ile Asp Leu Ala Asn Arg Glu Thr Ser Ile Phe 
                725                 730                 735     


Ser Tyr Arg Glu Asp Pro Ile Val Tyr Glu Ile His Pro Thr Lys Ser 
            740                 745                 750         


Phe Ile Ser Gly Gly Ser Thr Ile Thr Gly Val Gly Lys Asn Leu His 
        755                 760                 765             


Ser Val Ser Val Pro Arg Met Val Ile Asn Val His Glu Ala Gly Arg 
    770                 775                 780                 


Asn Phe Thr Val Ala Cys Gln His Arg Ser Asn Ser Glu Ile Ile Cys 
785                 790                 795                 800 


Cys Thr Thr Pro Ser Leu Gln Gln Leu Asn Leu Gln Leu Pro Leu Lys 
                805                 810                 815     


Thr Lys Ala Phe Phe Met Leu Asp Gly Ile Leu Ser Lys Tyr Phe Asp 
            820                 825                 830         


Leu Ile Tyr Val His Asn Pro Val Phe Lys Pro Phe Glu Lys Pro Val 
        835                 840                 845             


Met Ile Ser Met Gly Asn Glu Asn Val Leu Glu Ile Lys Gly Asn Asp 
    850                 855                 860                 


Ile Asp Pro Glu Ala Val Lys Gly Glu Val Leu Lys Val Gly Asn Lys 
865                 870                 875                 880 


Ser Cys Glu Asn Ile His Leu His Ser Glu Ala Val Leu Cys Thr Val 
                885                 890                 895     


Pro Asn Asp Leu Leu Lys Leu Asn Ser Glu Leu Asn Ile Glu Trp Lys 
            900                 905                 910         


Gln Ala Ile Ser Ser Thr Val Leu Gly Lys Val Ile Val Gln Pro Asp 
        915                 920                 925             


Gln Asn Phe Thr Gly Leu Ile Ala Gly Val Val Ser Ile Ser Ile Ala 
    930                 935                 940                 


Leu Leu Leu Leu Leu Gly Leu Phe Leu Trp Leu Lys Lys Arg Lys Gln 
945                 950                 955                 960 


Ile Lys Asp Leu Gly Ser Glu Leu Val Arg Tyr Asp Ala Arg Val His 
                965                 970                 975     


Thr Pro His Leu Asp Arg Leu Val Ser Ala Arg Ser Val Ser Pro Thr 
            980                 985                 990         


Thr Glu Met Val Ser Asn Glu Ser  Val Asp Tyr Arg Ala  Thr Phe Pro 
        995                 1000                 1005             


Glu Asp  Gln Phe Pro Asn Ser  Ser Gln Asn Gly Ser  Cys Arg Gln 
    1010                 1015                 1020             


Val Gln  Tyr Pro Leu Thr Asp  Met Ser Pro Ile Leu  Thr Ser Gly 
    1025                 1030                 1035             


Asp Ser  Asp Ile Ser Ser Pro  Leu Leu Gln Asn Thr  Val His Ile 
    1040                 1045                 1050             


Asp Leu  Ser Ala Leu Asn Pro  Glu Leu Val Gln Ala  Val Gln His 
    1055                 1060                 1065             


Val Val  Ile Gly Pro Ser Ser  Leu Ile Val His Phe  Asn Glu Val 
    1070                 1075                 1080             


Ile Gly  Arg Gly His Phe Gly  Cys Val Tyr His Gly  Thr Leu Leu 
    1085                 1090                 1095             


Asp Asn  Asp Gly Lys Lys Ile  His Cys Ala Val Lys  Ser Leu Asn 
    1100                 1105                 1110             


Arg Ile  Thr Asp Ile Gly Glu  Val Ser Gln Phe Leu  Thr Glu Gly 
    1115                 1120                 1125             


Ile Ile  Met Lys Asp Phe Ser  His Pro Asn Val Leu  Ser Leu Leu 
    1130                 1135                 1140             


Gly Ile  Cys Leu Arg Ser Glu  Gly Ser Pro Leu Val  Val Leu Pro 
    1145                 1150                 1155             


Tyr Met  Lys His Gly Asp Leu  Arg Asn Phe Ile Arg  Asn Glu Thr 
    1160                 1165                 1170             


His Asn  Pro Thr Val Lys Asp  Leu Ile Gly Phe Gly  Leu Gln Val 
    1175                 1180                 1185             


Ala Lys  Gly Met Lys Tyr Leu  Ala Ser Lys Lys Phe  Val His Arg 
    1190                 1195                 1200             


Asp Leu  Ala Ala Arg Asn Cys  Met Leu Asp Glu Lys  Phe Thr Val 
    1205                 1210                 1215             


Lys Val  Ala Asp Phe Gly Leu  Ala Arg Asp Met Tyr  Asp Lys Glu 
    1220                 1225                 1230             


Tyr Tyr  Ser Val His Asn Lys  Thr Gly Ala Lys Leu  Pro Val Lys 
    1235                 1240                 1245             


Trp Met  Ala Leu Glu Ser Leu  Gln Thr Gln Lys Phe  Thr Thr Lys 
    1250                 1255                 1260             


Ser Asp  Val Trp Ser Phe Gly  Val Leu Leu Trp Glu  Leu Met Thr 
    1265                 1270                 1275             


Arg Gly  Ala Pro Pro Tyr Pro  Asp Val Asn Thr Phe  Asp Ile Thr 
    1280                 1285                 1290             


Val Tyr  Leu Leu Gln Gly Arg  Arg Leu Leu Gln Pro  Glu Tyr Cys 
    1295                 1300                 1305             


Pro Asp  Pro Leu Tyr Glu Val  Met Leu Lys Cys Trp  His Pro Lys 
    1310                 1315                 1320             


Ala Glu  Met Arg Pro Ser Phe  Ser Glu Leu Val Ser  Arg Ile Ser 
    1325                 1330                 1335             


Ala Ile  Phe Ser Thr Phe Ile  Gly Glu His Tyr Val  His Val Asn 
    1340                 1345                 1350             


Ala Thr  Tyr Val Asn Val Lys  Cys Val Ala Pro Tyr  Pro Ser Leu 
    1355                 1360                 1365             


Leu Ser  Ser Glu Asp Asn Ala  Asp Asp Glu Val Asp  Thr 
    1370                 1375                 1380     


<210>  20
<211>  5
<212>  PRT
<213>  Homo sapiens

<400>  20

Arg Asp Glu Leu Thr 
1               5   


<210>  21
<211>  4
<212>  PRT
<213>  Homo sapiens

<400>  21

Arg Glu Glu Met 
1               


<210>  22
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Ile or or any other amino acid

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Ala or any other amino acid

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa is Tyr or any other amino acid

<400>  22

Gly Tyr Xaa Phe Thr Xaa Tyr Xaa Met His 
1               5                   10  


<210>  23
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Trp or any other amino acid

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is Lys or any other amino acid

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Asn or any other amino acid

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa is Asn or any other amino acid

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa is Leu or any other amino acid

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa is Ala or any other amino acid

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  Xaa is Asn or any other amino acid

<400>  23

Met Gly Xaa Ile Xaa Pro Xaa Xaa Gly Xaa Xaa Xaa Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa is Ser or any other amino acid

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Glu or any other amino acid

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Phe or any other amino acid

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa is Tyr or any other amino acid

<400>  24

Xaa Glu Ile Thr Thr Xaa Xaa Asp Xaa 
1               5                   


<210>  25
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  224G11 murine/humanized antibody HCDR1

<400>  25

Gly Tyr Ile Phe Thr Ala Tyr Thr Met His 
1               5                   10  


<210>  26
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  224G11 murine/humanized antibody HCDR2

<400>  26

Met Gly Trp Ile Lys Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  27
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  224G11 murine/humanized antibody HCDR3

<400>  27

Ser Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  28
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Asp or any other amino acid

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa is Asn or any other amino acid

<220>
<221>  misc_feature
<222>  (13)..(13)
<223>  Xaa is Phe or any other amino acid

<220>
<221>  misc_feature
<222>  (15)..(15)
<223>  Xaa is His or any other amino acid

<400>  28

Arg Ala Ser Gln Ser Val Xaa Ser Tyr Ala Xaa Ser Xaa Leu Xaa 
1               5                   10                  15  


<210>  29
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa is Arg or any other amino acid

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa is Ala or any other amino acid

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa is Thr or any other amino acid

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Ser or any other amino acid

<400>  29

Xaa Xaa Ser Xaa Arg Glu Xaa 
1               5           


<210>  30
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Ser or any other amino acid

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa is Lys or any other amino acid

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is Glu or any other amino acid

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Asp or any other amino acid

<400>  30

Gln Gln Xaa Xaa Xaa Xaa Pro Leu Thr 
1               5                   


<210>  31
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  224G11 murine/humanized antibody LCDR1

<400>  31

Lys Ser Ser Glu Ser Val Asp Ser Tyr Ala Asn Ser Phe Leu His 
1               5                   10                  15  


<210>  32
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  224G11 murine/humanized antibody LCDR2

<400>  32

Arg Ala Ser Thr Arg Glu Ser 
1               5           


<210>  33
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  224G11 murine/humanized antibody LCDR3

<400>  33

Gln Gln Ser Lys Glu Asp Pro Leu Thr 
1               5                   


<210>  34
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  34

Gly Tyr Thr Phe Thr Ser Tyr Thr Met His 
1               5                   10  


<210>  35
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  35

Met Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  36
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  36

Gln Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  37
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  37

Arg Ala Ser Gln Ser Val Ser Ser Tyr Ala Asn Ser Tyr Leu His 
1               5                   10                  15  


<210>  38
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  38

Arg Gly Ser Thr Arg Glu Ser 
1               5           


<210>  39
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  39

Gln Gln Ser Lys Ser Glu Pro Leu Thr 
1               5                   


<210>  40
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  40

Met Gly Trp Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  41
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  41

Gly Tyr Thr Phe Thr Ser Tyr Ala Met His 
1               5                   10  


<210>  42
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  42

Met Gly Trp Ile Asn Pro Asn Gly Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  43
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  43

Gly Tyr Ile Phe Thr Ser Tyr Ser Met His 
1               5                   10  


<210>  44
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  44

Met Gly Trp Ile Asn Pro Ser Asn Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  45
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  45

Gln Glu Ile Thr Thr Glu Phe Asp Ile 
1               5                   


<210>  46
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  46

Arg Ala Ser Gln Ser Val Glu Ser Tyr Ala Gln Ser Tyr Leu His 
1               5                   10                  15  


<210>  47
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  47

Gln Gln Ser Lys Ser Asp Pro Leu Thr 
1               5                   


<210>  48
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  48

Gly Tyr Ile Phe Thr Ser Tyr Thr Met His 
1               5                   10  


<210>  49
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  49

Met Gly Trp Ile Asn Pro Asn Gly Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  50
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  50

Ser Glu Ile Thr Thr Glu Gln Asp Tyr 
1               5                   


<210>  51
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  51

Arg Ala Ser Gln Ser Val Asp Ser Tyr Ala Asn Ser Tyr Leu His 
1               5                   10                  15  


<210>  52
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  52

Arg Ala Ser Gln Ser Val Glu Ser Tyr Ala Asn Ser Tyr Leu His 
1               5                   10                  15  


<210>  53
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  53

Gln Gln Tyr Gly Ser Glu Pro Leu Thr 
1               5                   


<210>  54
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  54

Met Gly Trp Ile Asn Pro Ser Gly Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  55
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  55

Ser Glu Ile Thr Thr Asp Phe Asp Tyr 
1               5                   


<210>  56
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  56

Arg Gly Ser Thr Arg Glu Thr 
1               5           


<210>  57
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  57

Arg Ala Ser Gln Ser Val Ser Ser Tyr Ala Gln Ser Tyr Leu His 
1               5                   10                  15  


<210>  58
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion consensus LCDR1

<400>  58

Lys Ser Ser Glu Ser Val Asp Ser Tyr Ala Asn Ser Phe Leu His 
1               5                   10                  15  


<210>  59
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion consensus LCDR2

<400>  59

Arg Ala Ser Thr Arg Glu Ser 
1               5           


<210>  60
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion consensus LCDR3

<400>  60

Gln Gln Ser Lys Glu Asp Pro Leu Thr 
1               5                   


<210>  61
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion consensus HCDR1

<400>  61

Gly Tyr Ile Phe Thr Ala Tyr Thr Met His 
1               5                   10  


<210>  62
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion consensus HCDR2

<400>  62

Met Gly Trp Ile Lys Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  63
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion consensus HCDR3

<400>  63

Ser Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  64
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Ile or Thr

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Ala or Ser

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa is Tyr Ser, Thr or Ala

<400>  64

Gly Tyr Xaa Phe Thr Xaa Tyr Xaa Met His 
1               5                   10  


<210>  65
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Trp or Ile

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is Lys or Asn

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Asn or Ser

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa is Asn or Gly

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa is Leu or Ser

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa is Ala or Thr

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  Xaa is Asn or Ser

<400>  65

Met Gly Xaa Ile Xaa Pro Xaa Xaa Gly Xaa Xaa Xaa Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  66
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa is Ser, Ala, Glu, His, Met, Gln, Thr or Val

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Glu or Asp

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Phe or Leu

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa is Tyr, Ala, Glu, Phe, Ile, Lys, Leu, Met, Gln, Ser, 
       Val or Trp

<400>  66

Xaa Glu Ile Thr Thr Xaa Xaa Asp Xaa 
1               5                   


<210>  67
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1


<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa is Ala, Ser or Thr

<400>  67

Gly Tyr Thr Phe Thr Ser Tyr Xaa Met His 
1               5                   10  


<210>  68
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Trp or Ile

<400>  68

Met Gly Xaa Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  69
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa is Ser, Ala, Glu, Gln or Thr

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Glu or Asp

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa is Tyr or Ile

<400>  69

Xaa Glu Ile Thr Thr Xaa Phe Asp Xaa 
1               5                   


<210>  70
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Asp, Ser or Glu

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa is Asn or Gln

<220>
<221>  misc_feature
<222>  (13)..(13)
<223>  Xaa is Phe or Tyr

<220>
<221>  misc_feature
<222>  (15)..(15)
<223>  Xaa is His or Ala

<400>  70

Arg Ala Ser Gln Ser Val Xaa Ser Tyr Ala Xaa Ser Xaa Leu Xaa 
1               5                   10                  15  


<210>  71
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa is Arg or Ala

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa is Ala or Gly

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa is Thr or Ser

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Thr or Ser

<400>  71

Xaa Xaa Ser Xaa Arg Glu Xaa 
1               5           


<210>  72
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Ser or Tyr

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa is Lys or Gly

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is Glu, Asp or Ser

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Asp, Ser, Glu or Arg

<400>  72

Gln Gln Xaa Xaa Xaa Xaa Pro Leu Thr 
1               5                   


<210>  73
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Asp, Ser or Glu

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa is Asn or Gln

<400>  73

Arg Ala Ser Gln Ser Val Xaa Ser Tyr Ala Xaa Ser Tyr Leu His 
1               5                   10                  15  


<210>  74
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa is Thr or Ser

<400>  74

Arg Gly Ser Thr Arg Glu Xaa 
1               5           


<210>  75
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Ser or Tyr

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa is Lys or Gly

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is Glu or Ser

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is Asp, Ser or Glu

<400>  75

Gln Gln Xaa Xaa Xaa Xaa Pro Leu Thr 
1               5                   


<210>  76
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  76

Gln Gln Ser Lys Ser Asp Pro Leu Thr 
1               5                   


<210>  77
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  77

Arg Ala Ser Thr Arg Glu Thr 
1               5           


<210>  78
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  78

Gly Tyr Thr Phe Thr Ser Tyr Ser Met His 
1               5                   10  


<210>  79
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  79

Met Gly Trp Ile Asn Pro Asn Gly Gly Leu Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Arg Gly 
            


<210>  80
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  80

Glu Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  81
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  81

Met Gly Trp Ile Asn Pro Asn Asn Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  82
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  82

Gln Gln Ser Lys Glu Glu Pro Leu Thr 
1               5                   


<210>  83
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  83

Gly Tyr Ile Phe Thr Ala Tyr Ser Met His 
1               5                   10  


<210>  84
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  84

Met Gly Ile Ile Lys Pro Ser Asn Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  85
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  85

Ala Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  86
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  86

Met Gly Trp Ile Lys Pro Asn Asn Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  87
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  87

Met Gly Trp Ile Lys Pro Asn Asn Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  88
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  88

Thr Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  89
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  89

Gln Gln Ser Gly Ser Ser Pro Leu Thr 
1               5                   


<210>  90
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  90

Gln Gln Tyr Gly Ser Ser Pro Leu Thr 
1               5                   


<210>  91
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  HAF peptide motif

<400>  91

Leu Leu Ile Tyr Arg Ala Ser Thr Arg 
1               5                   


<210>  92
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  HAF peptide motif

<400>  92

Ile Tyr Arg Ala Ser Thr Arg Glu Ser 
1               5                   


<210>  93
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  LAF peptide motif

<400>  93

Val Ala Val Tyr Tyr Cys Gln Gln Ser 
1               5                   


<210>  94
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  HAF peptide motif

<400>  94

Ile Phe Thr Ala Tyr Thr Met His 
1               5               


<210>  95
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  HAF peptide motif

<400>  95

Val Tyr Tyr Cys Ala Arg Ser Glu Ile 
1               5                   


<210>  96
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  LAF peptide motif

<400>  96

Met Gly Trp Ile Lys Pro Asn Asn Gly 
1               5                   


<210>  97
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  HAF peptide motif

<400>  97

Ile Phe Thr Ala Tyr Thr Met His Trp 
1               5                   


<210>  98
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  germline epitope peptide

<400>  98

Leu Glu Trp Met Gly Ile Ile Asn Pro 
1               5                   


<210>  99
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  germline epitope peptide

<400>  99

Met Gly Ile Ile Asn Pro Ser Gly Gly 
1               5                   


<210>  100
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  100

Gly Tyr Ile Phe Thr Ala Tyr Thr Met His 
1               5                   10  


<210>  101
<211>  5
<212>  PRT
<213>  Mus musculus

<400>  101

Ala Tyr Thr Met His 
1               5   


<210>  102
<211>  7
<212>  PRT
<213>  Mus musculus

<400>  102

Gly Tyr Ile Phe Thr Ala Tyr 
1               5           


<210>  103
<211>  8
<212>  PRT
<213>  Mus musculus

<400>  103

Gly Tyr Ile Phe Thr Ala Tyr Thr 
1               5               


<210>  104
<211>  12
<212>  PRT
<213>  Mus musculus

<400>  104

Ala Ser Gly Tyr Ile Phe Thr Ala Tyr Thr Met His 
1               5                   10          


<210>  105
<211>  6
<212>  PRT
<213>  Mus musculus

<400>  105

Thr Ala Tyr Thr Met His 
1               5       


<210>  106
<211>  19
<212>  PRT
<213>  Mus musculus

<400>  106

Met Gly Trp Ile Lys Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  107
<211>  17
<212>  PRT
<213>  Mus musculus

<400>  107

Trp Ile Lys Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys Phe Gln 
1               5                   10                  15      


Gly 
    


<210>  108
<211>  6
<212>  PRT
<213>  Mus musculus

<400>  108

Lys Pro Asn Asn Gly Leu 
1               5       


<210>  109
<211>  8
<212>  PRT
<213>  Mus musculus

<400>  109

Ile Lys Pro Asn Asn Gly Leu Ala 
1               5               


<210>  110
<211>  16
<212>  PRT
<213>  Mus musculus

<400>  110

Ile Lys Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys Phe Gln Gly 
1               5                   10                  15      


<210>  111
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  111

Trp Ile Lys Pro Asn Asn Gly Leu Ala Asn 
1               5                   10  


<210>  112
<211>  12
<212>  PRT
<213>  Mus musculus

<400>  112

Met Gly Trp Ile Lys Pro Asn Asn Gly Leu Ala Asn 
1               5                   10          


<210>  113
<211>  9
<212>  PRT
<213>  Mus musculus

<400>  113

Ser Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  114
<211>  11
<212>  PRT
<213>  Mus musculus

<400>  114

Ala Arg Ser Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   10      


<210>  115
<211>  8
<212>  PRT
<213>  Mus musculus

<400>  115

Ser Glu Ile Thr Thr Glu Phe Asp 
1               5               


<210>  116
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  116

Ala Arg Ser Glu Ile Thr Thr Glu Phe Asp 
1               5                   10  


<210>  117
<211>  15
<212>  PRT
<213>  Mus musculus

<400>  117

Lys Ser Ser Glu Ser Val Asp Ser Tyr Ala Asn Ser Phe Leu His 
1               5                   10                  15  


<210>  118
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  118

Glu Ser Val Asp Ser Tyr Ala Asn Ser Phe 
1               5                   10  


<210>  119
<211>  12
<212>  PRT
<213>  Mus musculus

<400>  119

Ser Ser Glu Ser Val Asp Ser Tyr Ala Asn Ser Phe 
1               5                   10          


<210>  120
<211>  12
<212>  PRT
<213>  Mus musculus

<400>  120

Val Asp Ser Tyr Ala Asn Ser Phe Leu His Trp Tyr 
1               5                   10          


<210>  121
<211>  7
<212>  PRT
<213>  Mus musculus

<400>  121

Arg Ala Ser Thr Arg Glu Ser 
1               5           


<210>  122
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  122

Leu Leu Ile Tyr Arg Ala Ser Thr Arg Glu 
1               5                   10  


<210>  123
<211>  9
<212>  PRT
<213>  Mus musculus

<400>  123

Gln Gln Ser Lys Glu Asp Pro Leu Thr 
1               5                   


<210>  124
<211>  6
<212>  PRT
<213>  Mus musculus

<400>  124

Ser Lys Glu Asp Pro Leu 
1               5       


<210>  125
<211>  8
<212>  PRT
<213>  Mus musculus

<400>  125

Gln Gln Ser Lys Glu Asp Pro Leu 
1               5               


<210>  126
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  h224G11-VH IGHV1-2

<400>  126

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Ala Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Lys Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Glu Ile Thr Thr Glu Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  127
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  VH graft IGHV1-46

<400>  127

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Ala Tyr 
            20                  25                  30          


Thr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Lys Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Glu Ile Thr Thr Glu Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  128
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  h224G11-VL IGKV4-1

<400>  128

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Glu Ser Val Asp Ser Tyr 
            20                  25                  30          


Ala Asn Ser Phe Leu His Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Arg Ala Ser Thr Arg Glu Ser Gly Val Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln Ser Lys 
                85                  90                  95      


Glu Asp Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  129
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  VL graft IGKV3-20

<400>  129

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Asp Ser Tyr 
            20                  25                  30          


Ala Asn Ser Phe Leu His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro 
        35                  40                  45              


Arg Leu Leu Ile Tyr Arg Ala Ser Thr Arg Glu Ser Gly Ile Pro Asp 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Ser Lys 
                85                  90                  95      


Glu Asp Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110     


<210>  130
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  130

Arg Ala Ser Gln Ser Val Asp Ser Tyr Ala Asn Ser Phe Leu Ala 
1               5                   10                  15  


<210>  131
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  131

Arg Ala Ser Gln Ser Val Asp Ser Tyr Ala Asn Ser Phe Leu His 
1               5                   10                  15  


<210>  132
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  132

Arg Ala Ser Gln Ser Val Asp Ser Tyr Ala Asn Ser Tyr Leu Ala 
1               5                   10                  15  


<210>  133
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  133

Arg Ala Ser Gln Ser Val Asp Ser Tyr Ala Gln Ser Phe Leu His 
1               5                   10                  15  


<210>  134
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  134

Arg Ala Ser Gln Ser Val Asp Ser Tyr Ala Gln Ser Tyr Leu Ala 
1               5                   10                  15  


<210>  135
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  135

Arg Ala Ser Gln Ser Val Asp Ser Tyr Ala Gln Ser Tyr Leu His 
1               5                   10                  15  


<210>  136
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  136

Arg Ala Ser Gln Ser Val Glu Ser Tyr Ala Asn Ser Phe Leu Ala 
1               5                   10                  15  


<210>  137
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  137

Arg Ala Ser Gln Ser Val Glu Ser Tyr Ala Asn Ser Tyr Leu Ala 
1               5                   10                  15  


<210>  138
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  138

Arg Ala Ser Gln Ser Val Glu Ser Tyr Ala Gln Ser Phe Leu His 
1               5                   10                  15  


<210>  139
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  139

Arg Ala Ser Gln Ser Val Ser Ser Tyr Ala Asn Ser Phe Leu His 
1               5                   10                  15  


<210>  140
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  140

Arg Ala Ser Gln Ser Val Ser Ser Tyr Ala Asn Ser Tyr Leu Ala 
1               5                   10                  15  


<210>  141
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  141

Arg Ala Ser Gln Ser Val Ser Ser Tyr Ala Gln Ser Phe Leu Ala 
1               5                   10                  15  


<210>  142
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR1

<400>  142

Arg Ala Ser Gln Ser Val Ser Ser Tyr Ala Gln Ser Phe Leu His 
1               5                   10                  15  


<210>  143
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  143

Ala Ala Ser Thr Arg Glu Ser 
1               5           


<210>  144
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  144

Ala Gly Ser Thr Arg Glu Ser 
1               5           


<210>  145
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  145

Ala Gly Ser Thr Arg Glu Thr 
1               5           


<210>  146
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  146

Arg Ala Ser Ser Arg Glu Ser 
1               5           


<210>  147
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  147

Arg Ala Ser Ser Arg Glu Thr 
1               5           


<210>  148
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  148

Arg Gly Ser Ser Arg Glu Ser 
1               5           


<210>  149
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR2

<400>  149

Arg Gly Ser Ser Arg Glu Thr 
1               5           


<210>  150
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  150

Gln Gln Ser Gly Glu Asp Pro Leu Thr Phe 
1               5                   10  


<210>  151
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  151

Gln Gln Ser Gly Glu Glu Pro Leu Thr Phe 
1               5                   10  


<210>  152
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  152

Gln Gln Ser Gly Glu Ser Pro Leu Thr Phe 
1               5                   10  


<210>  153
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  153

Gln Gln Ser Gly Ser Asp Pro Leu Thr Phe 
1               5                   10  


<210>  154
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  154

Gln Gln Ser Gly Ser Glu Pro Leu Thr Phe 
1               5                   10  


<210>  155
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  155

Gln Gln Ser Gly Ser Arg Pro Leu Thr Phe 
1               5                   10  


<210>  156
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  156

Gln Gln Ser Gly Ser Ser Pro Leu Thr Phe 
1               5                   10  


<210>  157
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  157

Gln Gln Ser Lys Glu Glu Pro Leu Thr Phe 
1               5                   10  


<210>  158
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  158

Gln Gln Ser Lys Glu Ser Pro Leu Thr Phe 
1               5                   10  


<210>  159
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  159

Gln Gln Ser Lys Ser Asp Pro Leu Thr Phe 
1               5                   10  


<210>  160
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  160

Gln Gln Ser Lys Ser Glu Pro Leu Thr Phe 
1               5                   10  


<210>  161
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  161

Gln Gln Ser Lys Ser Ser Pro Leu Thr Phe 
1               5                   10  


<210>  162
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  162

Gln Gln Tyr Gly Ser Asp Pro Leu Thr Phe 
1               5                   10  


<210>  163
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  163

Gln Gln Tyr Gly Ser Glu Pro Leu Thr Phe 
1               5                   10  


<210>  164
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  164

Gln Gln Tyr Lys Glu Glu Pro Leu Thr Phe 
1               5                   10  


<210>  165
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  165

Gln Gln Tyr Lys Glu Ser Pro Leu Thr Phe 
1               5                   10  


<210>  166
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  166

Gln Gln Tyr Lys Ser Asp Pro Leu Thr Phe 
1               5                   10  


<210>  167
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion LCDR3

<400>  167

Gln Gln Tyr Lys Ser Ser Pro Leu Thr Phe 
1               5                   10  


<210>  168
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  168

Gly Tyr Ile Phe Thr Ala Tyr Tyr Met His 
1               5                   10  


<210>  169
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  169

Gly Tyr Ile Phe Thr Ser Tyr Tyr Met His 
1               5                   10  


<210>  170
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  170

Gly Tyr Thr Phe Thr Ala Tyr Ser Met His 
1               5                   10  


<210>  171
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  171

Gly Tyr Thr Phe Thr Ala Tyr Thr Met His 
1               5                   10  


<210>  172
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  172

Gly Tyr Thr Phe Thr Ala Tyr Tyr Met His 
1               5                   10  


<210>  173
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR1

<400>  173

Gly Tyr Thr Phe Thr Ser Tyr Tyr Met His 
1               5                   10  


<210>  174
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  174

Met Gly Ile Ile Lys Pro Asn Gly Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  175
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  175

Met Gly Ile Ile Lys Pro Asn Gly Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  176
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  176

Met Gly Ile Ile Lys Pro Asn Asn Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  177
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  177

Met Gly Ile Ile Lys Pro Ser Asn Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  178
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  178

Met Gly Ile Ile Asn Pro Asn Asn Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  179
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  179

Met Gly Ile Ile Asn Pro Ser Gly Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  180
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  180

Met Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  181
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  181

Met Gly Trp Ile Lys Pro Asn Gly Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  182
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  182

Met Gly Trp Ile Lys Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  183
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  183

Met Gly Trp Ile Lys Pro Ser Asn Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  184
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  184

Met Gly Trp Ile Lys Pro Ser Asn Gly Ser Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  185
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  185

Met Gly Trp Ile Lys Pro Ser Asn Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  186
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  186

Met Gly Trp Ile Lys Pro Ser Asn Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  187
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  187

Met Gly Trp Ile Asn Pro Asn Gly Gly Leu Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  188
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  188

Met Gly Trp Ile Asn Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  189
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  189

Met Gly Trp Ile Asn Pro Asn Asn Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  190
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  190

Met Gly Trp Ile Asn Pro Ser Gly Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  191
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  191

Met Gly Trp Ile Asn Pro Ser Gly Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  192
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  192

Met Gly Trp Ile Asn Pro Ser Asn Gly Leu Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  193
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  193

Met Gly Ile Ile Lys Pro Ser Gly Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  194
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  194

Met Gly Ile Ile Lys Pro Ser Asn Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  195
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  195

Met Gly Ile Ile Asn Pro Asn Gly Gly Leu Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  196
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  196

Met Gly Ile Ile Asn Pro Asn Gly Gly Leu Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  197
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  197

Met Gly Ile Ile Asn Pro Asn Gly Gly Ser Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  198
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  198

Met Gly Ile Ile Asn Pro Asn Gly Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  199
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  199

Met Gly Ile Ile Asn Pro Asn Asn Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  200
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  200

Met Gly Ile Ile Asn Pro Ser Gly Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  201
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  201

Met Gly Ile Ile Asn Pro Ser Asn Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  202
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  202

Met Gly Ile Ile Asn Pro Ser Asn Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  203
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  203

Met Gly Ile Ile Asn Pro Ser Asn Gly Leu Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  204
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  204

Met Gly Ile Ile Asn Pro Ser Asn Gly Ser Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  205
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  205

Met Gly Trp Ile Lys Pro Asn Gly Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  206
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  206

Met Gly Trp Ile Lys Pro Asn Gly Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  207
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  207

Met Gly Trp Ile Lys Pro Asn Gly Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  208
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  208

Met Gly Trp Ile Lys Pro Asn Asn Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  209
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  209

Met Gly Trp Ile Asn Pro Asn Gly Gly Leu Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  210
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  210

Met Gly Trp Ile Asn Pro Asn Gly Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  211
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  211

Met Gly Trp Ile Asn Pro Asn Asn Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  212
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  212

Met Gly Trp Ile Asn Pro Ser Gly Gly Leu Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  213
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  213

Met Gly Trp Ile Asn Pro Ser Gly Gly Ser Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  214
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  214

Met Gly Trp Ile Asn Pro Ser Gly Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  215
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  215

Met Gly Ile Ile Lys Pro Asn Gly Gly Ser Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  216
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  216

Met Gly Ile Ile Lys Pro Asn Asn Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  217
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  217

Met Gly Ile Ile Lys Pro Ser Gly Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  218
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  218

Met Gly Ile Ile Lys Pro Ser Asn Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  219
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  219

Met Gly Ile Ile Asn Pro Asn Gly Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  220
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  220

Met Gly Ile Ile Asn Pro Asn Gly Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  221
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  221

Met Gly Ile Ile Asn Pro Asn Asn Gly Leu Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  222
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  222

Met Gly Ile Ile Asn Pro Ser Gly Gly Leu Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  223
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  223

Met Gly Ile Ile Asn Pro Ser Asn Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  224
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  224

Met Gly Ile Ile Asn Pro Ser Asn Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  225
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  225

Met Gly Trp Ile Lys Pro Asn Gly Gly Leu Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  226
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  226

Met Gly Trp Ile Lys Pro Asn Asn Gly Leu Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  227
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  227

Met Gly Trp Ile Lys Pro Asn Asn Gly Ser Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  228
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  228

Met Gly Trp Ile Lys Pro Ser Gly Gly Leu Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  229
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  229

Met Gly Trp Ile Lys Pro Ser Asn Gly Leu Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  230
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  230

Met Gly Trp Ile Lys Pro Ser Asn Gly Ser Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  231
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  231

Met Gly Trp Ile Asn Pro Asn Gly Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  232
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  232

Met Gly Trp Ile Asn Pro Asn Asn Gly Leu Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  233
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  233

Met Gly Trp Ile Asn Pro Asn Asn Gly Ser Ala Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  234
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  234

Met Gly Trp Ile Asn Pro Asn Asn Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  235
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  235

Met Gly Trp Ile Asn Pro Ser Gly Gly Leu Thr Asn Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  236
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  236

Met Gly Trp Ile Asn Pro Ser Asn Gly Ser Ala Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  237
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR2

<400>  237

Met Gly Trp Ile Asn Pro Ser Asn Gly Ser Thr Ser Tyr Ala Gln Lys 
1               5                   10                  15      


Phe Gln Gly 
            


<210>  238
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  238

His Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  239
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  239

Met Glu Ile Thr Thr Glu Phe Asp Tyr 
1               5                   


<210>  240
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  240

Gln Glu Ile Thr Thr Glu Leu Asp Tyr 
1               5                   


<210>  241
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  241

Ser Glu Ile Thr Thr Glu Glu Asp Tyr 
1               5                   


<210>  242
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  242

Ser Glu Ile Thr Thr Glu Phe Asp Ala 
1               5                   


<210>  243
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  243

Ser Glu Ile Thr Thr Glu Phe Asp Glu 
1               5                   


<210>  244
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  244

Ser Glu Ile Thr Thr Glu Phe Asp Phe 
1               5                   


<210>  245
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  245

Ser Glu Ile Thr Thr Glu Phe Asp Ile 
1               5                   


<210>  246
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  246

Ser Glu Ile Thr Thr Glu Phe Asp Lys 
1               5                   


<210>  247
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  247

Ser Glu Ile Thr Thr Glu Phe Asp Leu 
1               5                   


<210>  248
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  248

Ser Glu Ile Thr Thr Glu Phe Asp Met 
1               5                   


<210>  249
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  249

Ser Glu Ile Thr Thr Glu Phe Asp Gln 
1               5                   


<210>  250
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  250

Ser Glu Ile Thr Thr Glu Phe Asp Ser 
1               5                   


<210>  251
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  251

Ser Glu Ile Thr Thr Glu Phe Asp Val 
1               5                   


<210>  252
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  252

Ser Glu Ile Thr Thr Glu Phe Asp Trp 
1               5                   


<210>  253
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  253

Ser Glu Ile Thr Thr Glu Leu Asp Tyr 
1               5                   


<210>  254
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  254

Ser Glu Ile Thr Thr Glu Trp Asp Tyr 
1               5                   


<210>  255
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>  
<223>  anti-C-MET antibody molecule or antigen-binding portion HCDR3

<400>  255

Val Glu Ile Thr Thr Glu Phe Asp Leu 
1               5                   


